Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome

Published:2020-06-16 Issue:23 Volume:323 Page:2407
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Kim Byeong-Keuk¹,Hong Sung-Jin¹,Cho Yun-Hyeong²,Yun Kyeong Ho³,Kim Yong Hoon⁴,Suh Yongsung²,Cho Jae Young³,Her Ae-Young⁴,Cho Sungsoo⁵,Jeon Dong Woon⁶,Yoo Sang-Yong⁷,Cho Deok-Kyu⁸,Hong Bum-Kee⁹,Kwon Hyuckmoon⁹,Ahn Chul-Min¹,Shin Dong-Ho¹,Nam Chung-Mo¹⁰,Kim Jung-Sun¹,Ko Young-Guk¹,Choi Donghoon¹,Hong Myeong-Ki¹,Jang Yangsoo¹,

Affiliation:

1. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea

2. Myongji Hospital, Hanyang University College of Medicine, Goyang, South Korea

3. Wonkwang University Hospital, Iksan, South Korea

4. Kangwon National University School of Medicine, Chuncheon, South Korea

5. Dankook University Hospital, Dankook University College of Medicine, Cheonan, South Korea

6. National Health Insurance Service Ilsan Hospital, Goyang-City, South Korea

7. Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, South Korea

8. Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea

9. Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea

10. Department of Preventive Medicine and Biostatistics, Yonsei University College of Medicine, Seoul, South Korea

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2767161/jama_kim_2020_oi_200048.pdf

Reference28 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Levine;J Am Coll Cardiol,2016

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).;Valgimigli;Eur Heart J,2018

3. Prasugrel versus clopidogrel in patients with acute coronary syndromes.;Wiviott;N Engl J Med,2007

4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.;Wallentin;N Engl J Med,2009

5. Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial.;Park;Circulation,2019

Cited by 391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary syndromes;American Heart Journal;2024-11

2. Comparison between mono vs dual vs triple antiplatelet therapy in patients with ischemic heart disease undergoing PCI, a network meta-analysis;Current Problems in Cardiology;2024-11

3. Antithrombotic Therapy in Acute Coronary Syndrome;Interventional Cardiology Clinics;2024-10

4. Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs;European Journal of Clinical Pharmacology;2024-09-12

5. Comparative incidence and risk factors for gastrointestinal bleeding following percutaneous coronary intervention for coronary artery disease: Insights from the Keio Cardiovascular Registry in Japan;Thrombosis Research;2024-09